Invitrogen™ B3GALT6 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA5103652

Catalog No. PIPA5103652

Description

Antibody detects endogenous levels of total B3GALT6.

B3GALT6, Beta-1, 3-galactosyltransferase that transfers galactose from UDP-galactose to substrates with a terminal beta-linked galactose residue. B3GALT6 has a preference for galactose-beta-1, 4-xylose that is found in the linker region of glycosaminoglycans, such as heparan sulfate and chondroitin sulfate. B3GALT6 has no activity towards substrates with terminal glucosamine or galactosamine residues.

Specifications

• Antigen: B3GALT6
• Classification: Polyclonal
• Conjugate: Unconjugated
• Gene: B3GALT6
• Gene Alias: b3galt6; BB129894; Beta-1,3-galactosyltransferase 6; beta-1,3-GalTase 6; beta3GalT6; beta3Gal-T6; EDSP2; GAG GalTII; galactosyltransferase II; Galactosylxylosylprotein 3-beta-galactosyltransferase; GalTII; SEMDJL1; UDP-Gal:betaGal beta 1,3-galactosyltransferase 6; UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6; UDP-Gal:betaGal beta 1,3-galactosyltransferase, polypeptide 6; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 6
• Host Species: Rabbit
• Purification Method: Affinity chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 117592, 126792
• Content And Storage: -20°C
• Form: Liquid

• Applications: Western Blot, Immunocytochemistry
• Concentration: 1 mg/mL
• Formulation: PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
• Gene Accession No.: Q91Z92, Q96L58
• Gene Symbols: B3GALT6
• Immunogen: A synthesized peptide derived from human B3GALT6(Accession Q96L58), corresponding to amino acid residues H239-K289.
• Quantity: 100 μL
• Primary or Secondary: Primary
• Target Species: Human, Mouse
• Product Type: Antibody
• Isotype: IgG

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov